Literature DB >> 1988006

Detection of two species of low density lipoprotein particles in cholesteryl ester transfer protein deficiency.

N Sakai1, Y Matsuzawa, K Hirano, S Yamashita, S Nozaki, Y Ueyama, M Kubo, S Tarui.   

Abstract

By equilibrium density gradient ultracentrifugation, we analyzed the chemical composition and particle size of low density lipoproteins (LDLs) in 16 subfractions separated from the LDL fractions (1.019 less than d less than 1.063 g/ml) of two hyperalphalipoproteinemic patients who had a deficiency of cholesteryl ester transfer protein (CETP). The LDLs of these patients comprised a group of heterogeneous lipoprotein particles distributed almost equally in a wide density range from d = 1.025 g/ml to d = 1.053 g/ml, whereas LDLs from normal controls were a homogeneous group of lipoprotein particles distributed in a narrow density range from d = 1.030 g/ml to d = 1.046 g/ml. The LDL in each subfraction derived from the patients' plasma samples was poor in cholesteryl ester and rich in triglycerides and apolipoproteins. Each subfraction of normal control LDL contained only one species of homogeneous LDL particles, which progressively decreased in size with an increase in the density of the fraction. In contrast, each subfraction of patient LDL contained two species of LDL particles: smaller LDLs existed, in addition to those that were found to be identical to the normal control LDL particles observed in the corresponding subfractions. The intermediate density lipoproteins of the two patients were also composed of two species of lipoproteins. From these results, we speculate that two metabolic pathways may exist in the LDL formation process. In this process, the transfer of cholesteryl ester from high density lipoproteins by CETP may convert the smaller lipoprotein particles to the larger ones, forming the homogeneous LDL species.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1988006     DOI: 10.1161/01.atv.11.1.71

Source DB:  PubMed          Journal:  Arterioscler Thromb        ISSN: 1049-8834


  14 in total

1.  Low density lipoprotein heterogeneity in spontaneously hypercholesterolemic pigs.

Authors:  S T Cooper; R J Aiello; W J Checovich; A D Attie
Journal:  Mol Cell Biochem       Date:  1992-08-18       Impact factor: 3.396

2.  Changes in lipoprotein subfraction concentration and composition in healthy individuals treated with the CETP inhibitor anacetrapib.

Authors:  Ronald M Krauss; Kathleen Wojnooski; Joseph Orr; J Casey Geaney; Cathy Anne Pinto; Yang Liu; John A Wagner; Julie Mabalot Luk; Amy O Johnson-Levonas; Matt S Anderson; Hayes M Dansky
Journal:  J Lipid Res       Date:  2011-12-17       Impact factor: 5.922

3.  Multilocus genetic determinants of LDL particle size in coronary artery disease families.

Authors:  J I Rotter; X Bu; R M Cantor; C H Warden; J Brown; R J Gray; P J Blanche; R M Krauss; A J Lusis
Journal:  Am J Hum Genet       Date:  1996-03       Impact factor: 11.025

4.  Function of cholesteryl ester transfer protein in reverse cholesterol transport.

Authors:  R McPherson
Journal:  CMAJ       Date:  1993-06-15       Impact factor: 8.262

5.  Anacetrapib lowers LDL by increasing ApoB clearance in mildly hypercholesterolemic subjects.

Authors:  John S Millar; Gissette Reyes-Soffer; Patricia Jumes; Richard L Dunbar; Emil M deGoma; Amanda L Baer; Wahida Karmally; Daniel S Donovan; Hashmi Rafeek; Laura Pollan; Junichiro Tohyama; Amy O Johnson-Levonas; John A Wagner; Stephen Holleran; Joseph Obunike; Yang Liu; Rajasekhar Ramakrishnan; Michael E Lassman; David E Gutstein; Henry N Ginsberg; Daniel J Rader
Journal:  J Clin Invest       Date:  2015-05-11       Impact factor: 14.808

6.  A missense mutation in the cholesteryl ester transfer protein gene with possible dominant effects on plasma high density lipoproteins.

Authors:  K Takahashi; X C Jiang; N Sakai; S Yamashita; K Hirano; H Bujo; H Yamazaki; J Kusunoki; T Miura; P Kussie
Journal:  J Clin Invest       Date:  1993-10       Impact factor: 14.808

7.  Cholesteryl ester transfer protein inhibition in hypercholesterolemic hamsters: kinetics of apoprotein changes.

Authors:  S H Zuckerman; G F Evans
Journal:  Lipids       Date:  1995-04       Impact factor: 1.880

8.  Increased catabolic rate of low density lipoproteins in humans with cholesteryl ester transfer protein deficiency.

Authors:  K Ikewaki; M Nishiwaki; T Sakamoto; T Ishikawa; T Fairwell; L A Zech; M Nagano; H Nakamura; H B Brewer; D J Rader
Journal:  J Clin Invest       Date:  1995-09       Impact factor: 14.808

Review 9.  High density lipoprotein cholesterol: an evolving target of therapy in the management of cardiovascular disease.

Authors:  Navin K Kapur; Dominique Ashen; Roger S Blumenthal
Journal:  Vasc Health Risk Manag       Date:  2008

Review 10.  Unique features of high-density lipoproteins in the Japanese: in population and in genetic factors.

Authors:  Shinji Yokoyama
Journal:  Nutrients       Date:  2015-04-02       Impact factor: 5.717

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.